Results 211 to 220 of about 4,742,503 (345)

Estrogen receptor gene polymorphisms and endometrial cancer risk [PDF]

, 2000
Elisabete Weiderpass, I. Persson, Håkan Melhus, Sara Wedrén, Andreas Kindmark, John A. Baron   +5 more
openalex   +1 more source

Research and scholarly methods: Mitigating information bias

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
Abstract Whether designing a research study or considering changes to a patient's medication therapy based on published research, pharmacists must be knowledgeable about potential sources of bias in clinical research and how these threats to internal validity can be mitigated.
Gary L. Cochran, Hannah C. Cochran, Michael E. Ernst   +2 more
wiley   +1 more source

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification. [PDF]

BJC Rep
Yoshimura T, Nakamura K, Chiyoda T, Takamatsu R, Kawano R, Aimono E, Kawaida M, Sakai K, Masugi Y, Nishihara H, Yamagami W.   +10 more
europepmc   +1 more source

Significance of the cell block method in combination with cytology in mass screening for endometrial cancer.

, 1995
Hiromitsu Yabushita, Hiroshi Furuya, Yoshimi Mizuno, Yoshinori Koeda, Kazuo Hara, Masayoshi Noguchi, Masami Nakanishi   +6 more
openalex   +2 more sources

MEKK1 Activation of Human Estrogen Receptor α and Stimulation of the Agonistic Activity of 4-Hydroxytamoxifen in Endometrial and Ovarian Cancer Cells [PDF]

, 2000
Heehyoung Lee, Feng Jiang, Qiang Wang, Santo V. Nicosia, Jianhua Yang, Bing Su, Wenlong Bai   +6 more
openalex   +1 more source

Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations. [PDF]

, 2017
Cohn, David E, Goodfellow, Paul J, Kurita, Takeshi, Miranda, Mario A, Mutch, David G, O\u27Hern, Matthew J, Sapp, Caroline E, Serna, Vanida A, Walker, Christopher J   +8 more
core   +1 more source

Long Noncoding RNA TOB1‐AS1 Represses Cervical Cancer Cell Proliferation, Invasion, and Migration via the MicroRNA‐27a‐3p/Thioredoxin‐Interacting Protein Molecular Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Cervical cancer (CC) remains a major global health concern, particularly due to its aggressive nature and limited treatment options in advanced stages. Long noncoding RNA (lncRNA) TOB1‐AS1 has been proposed as a tumor suppressor, yet its regulatory mechanism in CC remains unclear.
Yang Wang, You‐Xiang Hou, Li Xie, Yi‐La Xia, Yi‐Na Wang   +4 more
wiley   +1 more source

Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report [PDF]

, 2017
Babb, Sheri, Divine, Laura M, Hagemann, Ian S, Mullen, Mary M, Powell, Matthew A   +4 more
core   +3 more sources

Clinical actionability of molecular targets in endometrial cancer

Nature Reviews. Cancer, 2019
M. Urick, D. Bell
semanticscholar   +1 more source

Smart Surface Engineering in Microcarriers: Toward Applications in Cancer Therapy

Macromolecular Materials and Engineering, EarlyView.
A microcarrier with dual surface modification integrates two distinct pH‐sensitive nanoreservoirs, enabling precise, site‐specific drug delivery and potential extracellular matrix degradation. This dual functionalization strategy ensures the separation of therapeutic functions, effectively preventing cross‐process interference and aiming synergistic ...
Fatemeh Rajabasadi, Silvia Moreno, Mercedes Gonzalez Rico, Pedro Viñola, Kristin Fichna, Franziska Hebenstreit, Susanne Boye, Andreas Janke, Dietmar Appelhans, Mariana Medina‐Sánchez   +9 more
wiley   +1 more source